Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment
Status:
Completed
Trial end date:
2018-10-30
Target enrollment:
Participant gender:
Summary
This project seeks to determine whether estradiol suppression achieved with adjuvant
treatment with an aromatase inhibitor improves end-follicular and midluteal phase parameters
during IVF. 128 patients will be randomized to either placebo or active treatment.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Sven O. Skouby
Collaborators:
Copenhagen University Hospital, Denmark Holbaek Sygehus Hvidovre University Hospital Region Capital Denmark Rigshospitalet, Denmark Skåne University Hospital Zealand University Hospital